Phase
Alumni community member
in2cure
in2cure aims to develop novel treatments based on nature’s own defenses – evolutionary old biological systems which normally keep us healthy. It specializes in the development of proprietary peptide-based drugs for prevention and treatment of inflammatory diseases, infections, wound and surgical complications.
Helene holds a Master’s degree in Chemical Engineering from Lund Technical University. She is a strategic leader with 25 years’ experience in product, technology and business development. She as an extensive experience in driving change and reaching results by building bridges between stakeholders, often in complex intercultural environments.
Did you know?
in2cure’s product, BioC, is synthetically produced, but has a sequence identical to those fragments already present in the human body.
Non-invasive cardiac pressure monitoring device
Accelerated drug development in oncology
Unique stem cell therapeutics
3D cell culture systems
Rapid Diagnostics for Multi-pathogen detection
Individualised information of the intestinal flora
Imaging solutions for life sciences
Novel probiotics for therapeutic effect
Treatments based on nature’s own defenses
Pest control solutions for bed bugs
Neonatal Lung Analyzer
Prebiotics for irritable bowel syndrome
Nanotechnology based infection control
Excellence in designing & executing drug discovery
Models for autoimmune & inflammatory conditions
Ultrasensitive cancer diagnostics & monitoring
Structural biology & drug discovery services
Male-Factor Infertility Diagnostics
Customized in vitro and in vivo services
Stroke detection device
Wound treatment gel
Regenerative medicine & cancer
